InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Corrigan Mark, 董事. Director active across 2 companies, notably Nabriva Therapeutics plc. Aggregated, 5 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €110k. Activity tracked since 28 July 2021. The latest transaction was disclosed on 8 December 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Mark Corrigan is a Board Member at Nabriva Therapeutics plc. He contributes to the governance of the company by participating in strategic decision-making and ensuring operational compliance. His role is important for the success and growth of the company.